Wearable Robot for Kids

Ekso Bionics Holdings, Inc. (OTCQB: EKSO), a robotic exoskeleton company, announced today that it has been awarded a P20 Exploratory Grant from the National Institutes of Health (NIH) to continue the development of an exoskeleton prototype for children. This work will be done with collaboration between the pediatric rehabilitation department at the UCSF Benioff Children’s Hospital Oakland and Ekso Bionics. This project will consist of Ekso Bionics developing a pediatric version of its Ekso GTTM robotic exoskeleton. Working with UCSF Benioff Children’s Hospital Oakland allows for effective integration of advanced robotics into a world-class pediatric rehabilitative practice. 

Ekso Bionics is collaborating with Christine Aguilar, MD, Medical Director, Pediatric Rehabilitation Medicine and Robert Haining, MD, Associate Director, Rehabilitation Medicine of UCSF Benioff Children’s Hospital Oakland on suit design and function to be used for children with neurologic disorders that result in gait deficiencies such as spinal cord injury, stroke, traumatic brain injury and cerebral palsy. The suit will be developed for children aged five (approximately 42 inches tall and 40 pounds) to about eight years old (approximately 50 inches tall and 56 pounds). Doctors Aguilar and Haining are also providing input on potential clinical testing and implementation of the suits. Following the development of an effective pediatric prototype, Ekso and UCSF Benioff Children’s Hospital Oakland will discuss a sequential Phase II Grant.

“Our department is very excited to be collaborating with Ekso Bionics," said Dr. Aguilar. "We believe the new prototype of exoskeleton will give children who have difficulty moving their legs the ability to walk."

“This NIH grant and partnership with UCSF Benioff Children’s Hospital Oakland gives us the real opportunity to intervene early in a child’s life and potentially help them improve their walking skills and overall quality of life,” said Katie Strausser, PhD, and Director of Research at Ekso Bionics.

About Ekso Bionics

Since 2005, Ekso Bionics has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. The company's first commercially available product called Ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. By designing and creating some of the most forward-thinkingand innovative solutions for people looking to augment human capabilities, Ekso Bionics is helping people rethink current physical limitations and achieve the remarkable.

Ekso Bionics is headquartered in Richmond, CA and is listed on the OTC QB under the symbol EKSO. To learn more about Ekso Bionics please visit us at www.eksobionics.com.

Facebook: www.facebook.com/eksobionics
Twitter: @eksobionics
YouTube: http://www.youtube.com/user/EksoBionics/

 

More News

Autism Researchers Discover Genetic ‘Rosetta Stone’

New findings could unlock mysteries about how early brain development may lead to autism.

Details

CHORI Researchers Receive St. Baldrick’s Grant

Funds to support Oakland's early-phase and novel therapeutics program.

Details

New Year, New Leadership

Pediatrician Dr. Michael R. Anderson is appointed to head the children's hospitals.

Details